News
FF was measured by dedicated software (AccuICAD) before and after stenting. During follow-up, patients were categorized into two groups based on the occurrence of in-stent restenosis (ISR): ISR group ...
KUWAIT CITY, April 19: Kuwait's Chest Diseases Hospital has announced the successful implantation of two coronary artery stents in patients suffering from intractable angina pectoris. Dr. Abdullah ...
For the first time, astronomers have confirmed the existence of a lone black hole — one with no star orbiting it. It’s “the only one so far,” says Kailash Sahu, an astronomer at the Space ...
Credit: Explode / Shutterstock. The coronary stent market in the Asia-Pacific (APAC) region is witnessing sustained growth, driven by rising coronary artery disease (CAD) prevalence, an ageing ...
DeepTek announces that its Chest X-ray AI solution has received CE certification under the European Union Medical Device Regulation (EU MDR) as a Class IIb medical device. The Chest X-ray AI solution ...
Dear Doctor: Dr. Roach’s suggested treatment for laryngeal neuropathy works wonders for this patient
G.S. ANSWER: I have written about laryngeal neuropathy -- an uncommon condition causing chronic cough or throat clearing -- several times, and each time I do, I get letters from people saying it ...
First Dual-Layer Micromesh Carotid Stent Approved for Use in the U.S. ALISO VIEJO, Calif., April 15, 2025 /PRNewswire/ -- Terumo Neuro, a global leader in neurovascular innovation and a wholly ...
Terumo Neuro (formerly MicroVention) announced today that it received FDA premarket approval (PMA) for its Carotid Stent System. Aliso Viejo, California-based Terumo Neuro says this marks the ...
April 15, 2025—Terumo Neuro, a wholly owned subsidiary of Terumo Corporation, announced that the company’s dual-layer micromesh carotid stent system has received premarket approval from the FDA for ...
First Dual-Layer Micromesh Carotid Stent Approved for Use in the U.S. ALISO VIEJO, Calif., April 15, 2025 /PRNewswire/ -- Terumo Neuro, a global leader in neurovascular innovation and a wholly owned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results